TEMPORARY REMOVAL: VP.47 Interleukin 31 (IL-31) inhibition as a trigger for an immune-mediated myopathy?

Winkler M, Kappes-Horn K, Reimann J

Open source

DOI
10.1016/j.nmd.2022.07.178
Published
2022 Oct
Container
Neuromuscular disorders : NMD
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nmd.2022.07.178,
  title = {TEMPORARY REMOVAL: VP.47 Interleukin 31 (IL-31) inhibition as a trigger for an immune-mediated myopathy?},
  author = {Winkler M and Kappes-Horn K and Reimann J},
  year = {2022},
  journal = {Neuromuscular disorders : NMD},
  doi = {10.1016/j.nmd.2022.07.178},
  url = {https://doi.org/10.1016/j.nmd.2022.07.178}
}

RIS

TY  - JOUR
TI  - TEMPORARY REMOVAL: VP.47 Interleukin 31 (IL-31) inhibition as a trigger for an immune-mediated myopathy?
AU  - Winkler M
AU  - Kappes-Horn K
AU  - Reimann J
PY  - 2022
JO  - Neuromuscular disorders : NMD
DO  - 10.1016/j.nmd.2022.07.178
UR  - https://doi.org/10.1016/j.nmd.2022.07.178
ER  - 

APA

M, W., K, K., & J, R. (2022). TEMPORARY REMOVAL: VP.47 Interleukin 31 (IL-31) inhibition as a trigger for an immune-mediated myopathy?. Neuromuscular disorders : NMD. https://doi.org/10.1016/j.nmd.2022.07.178

Source records